메뉴 건너뛰기
Brain
Volumn 138, Issue 2, 2015, Pages 242-244
Can levodopa-induced dyskinesias go beyond the motor circuit?
Author keywords

[No Author keywords available]
Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;
EID: 84922354885     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu365     Document Type: Note
Times cited : (8)
References (11)
  • 1
    • 84858170198 scopus 로고    scopus 로고
    • Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia
    • Aron AR, Obeso J. Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia. Mov Disord 2012; 27: 339-40.
    • (2012) Mov Disord. , vol.27 , pp. 339-340
    • Aron, A.R.1    Obeso, J.2
  • 2
    • 79955089728 scopus 로고    scopus 로고
    • Increased prefrontal volume in pd with levodopa-induced dyskinesias: A voxel-based morphometry study
    • Cerasa A, Messina D, Pugliese P, Morelli M, Lanza P, Salsone M, et al. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Mov Disord 2011; 26: 807-12.
    • (2011) Mov Disord. , vol.26 , pp. 807-812
    • Cerasa, A.1    Messina, D.2    Pugliese, P.3    Morelli, M.4    Lanza, P.5    Salsone, M.6
  • 3
    • 84858180734 scopus 로고    scopus 로고
    • Prefrontal alterations in parkinson's disease with levodopainduced dyskinesia during fmri motor task
    • Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, Salsone M, et al. Prefrontal alterations in Parkinson's disease with levodopainduced dyskinesia during fMRI motor task. Mov Disord 2012; 27: 364-71.
    • (2012) Mov Disord. , vol.27 , pp. 364-371
    • Cerasa, A.1    Pugliese, P.2    Messina, D.3    Morelli, M.4    Gioia, M.C.5    Salsone, M.6
  • 4
    • 84922354892 scopus 로고    scopus 로고
    • A network centred on the inferior frontal cortex is critically involved in levodopainduced dyskinesias
    • Cerasa A, Koch G, Donzuso G, et al. A network centred on the inferior frontal cortex is critically involved in levodopainduced dyskinesias. Brain 2015; 138: 414-27.
    • (2015) Brain. , vol.138 , pp. 414-427
    • Cerasa, A.1    Koch, G.2    Donzuso, G.3
  • 5
    • 0034109726 scopus 로고    scopus 로고
    • The spectrum of levodopa-induced dyskinesias
    • Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000, 47 (Suppl 1): 2-9.
    • (2000) Ann Neurol. , vol.47 , pp. 2-9
    • Fahn, S.1
  • 6
    • 0032985924 scopus 로고    scopus 로고
    • Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for parkinson's disease
    • Gross RE, Lombardi WJ, Lang AE, Duff J, Hutchison WD, Saint-Cyr JA, et al. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain 1999; 122: 405-16.
    • (1999) Brain. , vol.122 , pp. 405-416
    • Gross, R.E.1    Lombardi, W.J.2    Lang, A.E.3    Duff, J.4    Hutchison, W.D.5    Saint-Cyr, J.A.6
  • 7
    • 84920921975 scopus 로고    scopus 로고
    • Four pioneers of l-dopa treatment: Arvid carlsson, oleh hornykiewicz, george cotzias and melvin yahr
    • Lees A, Tolosa E, Olanow CW. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias and Melvin Yahr. Mov Disord 2015; 30: 3-6.
    • (2015) Mov Disord. , vol.30 , pp. 3-6
    • Lees, A.1    Tolosa, E.2    Olanow, C.W.3
  • 8
    • 0034109592 scopus 로고    scopus 로고
    • Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: Problems with the current model
    • Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol 2000, 47 (4 Suppl 1): 22-32.
    • (2000) Ann Neurol. , vol.47 , Issue.4 , pp. 22-32
    • Obeso, J.A.1    Rodriguez-Oroz, M.C.2    Rodriguez, M.3    Delong, M.R.4    Olanow, C.W.5
  • 9
    • 0027286045 scopus 로고
    • Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey
    • Page RD, Sambrook MA, Crossman AR. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience 1993; 55: 147-65.
    • (1993) Neuroscience. , vol.55 , pp. 147-165
    • Page, R.D.1    Sambrook, M.A.2    Crossman, A.R.3
  • 10
    • 0036813609 scopus 로고    scopus 로고
    • Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat
    • Périer C, Tremblay L, Féger J, Hirsch EC. Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat. J Neurosci 2002; 22: 8711-19.
    • (2002) J Neurosci. , vol.22 , pp. 8711-8719
    • Périer, C.1    Tremblay, L.2    Féger, J.3    Hirsch, E.C.4
  • 11
    • 0031882302 scopus 로고    scopus 로고
    • Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia
    • Rascol O, Sabatini U, Brefel C, Fabre N, Rai S, Senard JM, et al. Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain 1998; 121: 527-33
    • (1998) Brain. , vol.121 , pp. 527-533
    • Rascol, O.1    Sabatini, U.2    Brefel, C.3    Fabre, N.4    Rai, S.5    Senard, J.M.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.